Pivotal bioVenture Partners China Closes Maiden Fund, at $150M

Pivotal bioVenture Partners China, a member of Nan Fung Life Sciences (NLFS), has closed its inaugural fund at $150m.

Pivotal bioVenture Partners China USD Fund I will focus on incubating and building life sciences companies in China.

Founded by Mr. Vincent Cheung, who is the Chairman of NFLS and Managing Director and COO of Nan Fung Group, and led by Dr. Jimmy Wei, Mr. Meng Gao and Mr. Shannon Cheung, Pivotal China will focus on incubating new life sciences companies in China by in-licensing innovative products and technologies that could serve unmet medical needs of the China market.
Pivotal China will invest broadly in pharmaceuticals, devices and service sectors.

Dr. Jimmy Wei was the Managing Partner at iBridge Capital and the Partner at the KPCB China fund, where he was involved with the formation of companies such as Zai Lab, JHL Biotech, XW Lab and iMab.
Mr. Meng Gao was a Managing Director at Blackstone’s Private Equity Group.
Mr. Shannon Cheung was the Founder and Chief Executive Officer of Averest Capital, an investment company focusing on healthcare, TMT and environmental technology sectors and Co-Founder and Vice Chairman of Likang Life Sciences.



Join the discussion